126 related articles for article (PubMed ID: 1450440)
1. Salvage chemotherapy with mitoxantrone and mitomycin with or without methotrexate in advanced breast cancer.
Astone A; Cassano A; Fontana T; Noviello MR; Pozzo C; Barone C
Anticancer Drugs; 1992 Oct; 3(5):471-3. PubMed ID: 1450440
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C and mitoxantrone chemotherapy for advanced breast cancer: efficacy with minimal gastrointestinal toxicity and alopecia.
Panasci L; Shenouda G; Begin L; Pollak M; Reinke A; Margolese R
Cancer Chemother Pharmacol; 1990; 26(6):457-60. PubMed ID: 2121379
[TBL] [Abstract][Full Text] [Related]
3. A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
Jodrell DI; Smith IE; Mansi JL; Pearson MC; Walsh G; Ashley S; Sinnett HD; McKinna JA
Br J Cancer; 1991 May; 63(5):794-8. PubMed ID: 2039705
[TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
5. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Smith IE; Powles TJ
Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
[TBL] [Abstract][Full Text] [Related]
6. A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
Alonso MC; Tabernero JM; Ojeda B; Llanos M; Solà C; Climent MA; Seguí MA; López JJ
Breast Cancer Res Treat; 1995 Apr; 34(1):15-24. PubMed ID: 7749156
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
[TBL] [Abstract][Full Text] [Related]
8. [A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers].
Degardin M; Hecquet B; Bonneterre J; Adenis A; Pion JM; Demaille A
Bull Cancer; 1992; 79(2):169-76. PubMed ID: 1392155
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG).
Andersson M; Madsen EL; Overgaard M; Rose C; Dombernowsky P; Mouridsen HT
Eur J Cancer; 1999 Jan; 35(1):39-46. PubMed ID: 10211086
[TBL] [Abstract][Full Text] [Related]
10. Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer.
Bezwoda WR; Hesdorffer CS; Dansey RD
S Afr Med J; 1987 Oct; 72(7):465-7. PubMed ID: 3660150
[TBL] [Abstract][Full Text] [Related]
11. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
[TBL] [Abstract][Full Text] [Related]
12. CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study.
Ron IG; Wigler N; Borovik R; Brufman G; Rizel S; Shani A; Brenner J; Farbstein H; Dale A; Inbar MJ; Brenner HJ; Chaitchik S; Catane R
Am J Clin Oncol; 2001 Aug; 24(4):323-7. PubMed ID: 11474254
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
Perrone F; De Placido S; Carlomagno C; Gravina A; De Laurentiis M; Del Mastro L; Gridelli C; Pagliarulo C; Bianco AR
Am J Clin Oncol; 1994 Jun; 17(3):218-22. PubMed ID: 8192105
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast.
Harper-Wynne C; English J; Meyer L; Bower M; Archer C; Sinnett HD; Lowdell C; Coombes RC
Br J Cancer; 1999 Sep; 81(2):316-22. PubMed ID: 10496359
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.
Repetto L; Miglietta L; Gardin G; Naso C; Giudici S; Merlini L; Queirolo P; Campora E; Pronzato P; Rosso R
Ann Oncol; 1992 Feb; 3(2):165-6. PubMed ID: 1606088
[TBL] [Abstract][Full Text] [Related]
16. CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups.
Ron IG; Wigler N; Borovik R; Peretz T; Rizel S; Shani A; Brenner J; Farbstein H; Brenner HJ; Chaitchik S; Catane R; Inbar MJ
Am J Clin Oncol; 2002 Oct; 25(5):520-2. PubMed ID: 12393997
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
[TBL] [Abstract][Full Text] [Related]
18. Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial.
Stein RC; Bower M; Law M; Bliss JM; Barton C; Gazet JC; Ford HT; Coombes RC
Eur J Cancer; 1992; 28A(12):1963-5. PubMed ID: 1419290
[TBL] [Abstract][Full Text] [Related]
19. [CMF or CAF combination chemotherapy for breast cancer].
Ota J
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
Içli F; Günel N; Dinçol D; Karaoğuz H; Demirkazik A
J Surg Oncol; 1992 Aug; 50(4):251-3. PubMed ID: 1640710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
